Quidel Corporation

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Ortho Clinical Diagnostics Holdings plc Buyout

Retrieved on: 
Monday, December 27, 2021

announces that it is investigating Ortho Clinical Diagnostics Holdings plc (Ortho) (NASDAQ GS: OCDX ) regarding possible breaches of fiduciary duties and other violations of law related to Orthos agreement to be acquired by Quidel Corporation (NASDAQ GS: QDEL ).

Key Points: 
  • announces that it is investigating Ortho Clinical Diagnostics Holdings plc (Ortho) (NASDAQ GS: OCDX ) regarding possible breaches of fiduciary duties and other violations of law related to Orthos agreement to be acquired by Quidel Corporation (NASDAQ GS: QDEL ).
  • Under the terms of the agreement, Orthos shareholders will receive $24.68 in cash for each share of Ortho common stock they own.
  • To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-ortho-clinical-diagnostics-holdings-plc .
  • You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected] .

SKIL, OCDX, HXOH, CSPR STOCK ALERT: Halper Sadeh LLP Investigates Mergers of SKIL, OCDX, HXOH, CSPR; Shareholders are Encouraged to Contact the Firm

Retrieved on: 
Friday, December 24, 2021

Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)concerning potential violations ofthe federal securities laws and/or breaches of fiduciary duties relating to its sale to Quidel Corporation.

Key Points: 
  • Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)concerning potential violations ofthe federal securities laws and/or breaches of fiduciary duties relating to its sale to Quidel Corporation.
  • Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
  • Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options.
  • Halper Sadeh LLPrepresents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

Investor Alert: The M&A Class Action Firm Announces an Investigation of the Merger

Retrieved on: 
Friday, December 24, 2021

NEW YORK, Dec. 23, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm ratedTop 50in the 2018-2020 ISS Securities Class Action Services Report and headquartered at theEmpire State Buildingin New York City, is investigating:

Key Points: 
  • NEW YORK, Dec. 23, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm ratedTop 50in the 2018-2020 ISS Securities Class Action Services Report and headquartered at theEmpire State Buildingin New York City, is investigating:
    Alpha Capital Acquisition Co. ( ASPC ), relating to its merger with Semantix.
  • Under the terms of the agreement, OCDX shareholders will receive 0.1055 shares of Quidel and $7.14 in cash per share they own.
  • We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing.
  • Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

ORTHO CLINICAL DIAGNOSTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of OCDX and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, December 23, 2021

On December 23, 2021, Ortho announced that it had entered into an agreement to be acquired by Quidel in a deal valued at approximately $6 billion.

Key Points: 
  • On December 23, 2021, Ortho announced that it had entered into an agreement to be acquired by Quidel in a deal valued at approximately $6 billion.
  • Pursuant to the merger agreement, Ortho stockholders will receive $7.14 in cash and 0.1055 shares of Quidel common stock for each share of Ortho common stock owned.
  • Bragar Eagel & Squire is concerned that Orthos board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Quidel (QDEL) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Quidel Corporation is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – QDEL

Retrieved on: 
Thursday, December 23, 2021

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Quidel Corporation (NASDAQ: QDEL) and Ortho Clinical Diagnostics Holdings plc is fair to Quidel shareholders.

Key Points: 
  • Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Quidel Corporation (NASDAQ: QDEL) and Ortho Clinical Diagnostics Holdings plc is fair to Quidel shareholders.
  • On behalf of Quidel shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
  • Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.
  • Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Ortho Clinical (OCDX) Stock Alert: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Ortho Clinical Diagnostics Holdings PLC Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – OCDX

Retrieved on: 
Thursday, December 23, 2021

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) to Quidel Corporation is fair to Ortho shareholders.

Key Points: 
  • Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) to Quidel Corporation is fair to Ortho shareholders.
  • Under the terms of the proposed agreement, Ortho shareholders will receive $7.14 in cash per common share and 0.1055 shares of common stock in the combined company for each Ortho common share, with Ortho shareholders expected to own approximately 38% of the combined company.
  • On behalf of Ortho shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
  • Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics

Retrieved on: 
Thursday, December 23, 2021

Quidel Corporation (NASDAQ: QDEL) (Quidel) and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (Ortho) today announced that they have entered into a definitive agreement in which Quidel will acquire Ortho, one of the worlds largest in vitro diagnostics companies, for $24.68 per share of common stock using a combination of cash and newly issued shares in the combined company, representing a 25% premium over Orthos closing price on December 22, 2021 and an equity value of approximately $6.0 billion.

Key Points: 
  • Quidel Corporation (NASDAQ: QDEL) (Quidel) and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (Ortho) today announced that they have entered into a definitive agreement in which Quidel will acquire Ortho, one of the worlds largest in vitro diagnostics companies, for $24.68 per share of common stock using a combination of cash and newly issued shares in the combined company, representing a 25% premium over Orthos closing price on December 22, 2021 and an equity value of approximately $6.0 billion.
  • The combined organization will unite world-class technologies and platforms to benefit customers with expanded access to clinical chemistry, immunoassay, molecular diagnostics, immunohematology, donor screening, and point-of-care diagnostics offerings.
  • Both Quidel and Ortho have talented and experienced employees who share a commitment to customers, patients, and the communities the companies serve.
  • Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the worlds largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care.

DGAP-News: Series of Infographics From Quidel Corporation Helps Educate Consumers on the Characteristics, Warning Signs and Prevalence of Lyme Disease

Retrieved on: 
Monday, December 20, 2021

Series of Infographics From Quidel Corporation Helps Educate Consumers on the Characteristics, Warning Signs and Prevalence of Lyme Disease

Key Points: 
  • Series of Infographics From Quidel Corporation Helps Educate Consumers on the Characteristics, Warning Signs and Prevalence of Lyme Disease
    The issuer is solely responsible for the content of this announcement.
  • With Lyme disease being identified in record numbers throughout the country, Quidel releases a series of consumer-friendly infographics to help educate Americans on its characteristics, warning signs, seasonality and areas of prevalence.
  • 'These infographics provide the information people are seeking in an easy-to-understand manner, and we encourage anyone who spends any time outdoors to educate themselves on this vitally important topic.'
  • Quidel is the diagnostic health care manufacturer behind the industry's most rapid and reliable in-office test for Lyme disease, the Sofia(R) 2 Lyme FIA test.

Quidel Announces Sponsorship and Community Partnership With the Chicago Blackhawks

Retrieved on: 
Wednesday, December 15, 2021

Quidel Corporation (NASDAQ: QDEL) (Quidel), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, has executed a multi-year partnership agreement with the Chicago Blackhawks to sponsor team promotions and community services.

Key Points: 
  • Quidel Corporation (NASDAQ: QDEL) (Quidel), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, has executed a multi-year partnership agreement with the Chicago Blackhawks to sponsor team promotions and community services.
  • We look forward to working with the Blackhawks, Fifth Third Arena, and the Chicago Blackhawks Foundation on initiatives that address current community health needs in ways that can create a positive impact.
  • We are grateful to Quidel for their donation of QuickVue At-Home OTC COVID-19 Tests to a number of our Chicago Blackhawks Foundation partners, who each serve our neighboring West Side community in a unique way, said Sara Guderyahn, Blackhawks Vice President of Community Partnerships & Executive Director of the Chicago Blackhawks Foundation.
  • As the Chicago Blackhawks official charitable arm, the Chicago Blackhawks Foundation works to create a healthier, smarter, more secure world for children and families across Chicagoland.

Series of Infographics From Quidel Corporation Helps Educate Consumers on the Characteristics, Warning Signs and Prevalence of Lyme Disease

Retrieved on: 
Tuesday, December 14, 2021

With Lyme disease being identified in record numbers throughout the country, a series of consumer-friendly infographics has been released by Quidel to help educate Americans on its characteristics, warning signs, seasonality and areas of prevalence.

Key Points: 
  • With Lyme disease being identified in record numbers throughout the country, a series of consumer-friendly infographics has been released by Quidel to help educate Americans on its characteristics, warning signs, seasonality and areas of prevalence.
  • These infographics provide the information people are seeking in an easy-to-understand manner, and we encourage anyone who spends any time outdoors to educate themselves on this vitally important topic.
  • There is also a map showing those states where various types of ticks are most prevalent.
  • Quidel is the diagnostic health care manufacturer behind the industrys most rapid and reliable in-office test for Lyme disease, the Sofia 2 Lyme FIA test.